When did the USPTO start requiring Sequence Listing XML for patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The USPTO began requiring Sequence Listing XML for certain patent…
Read MoreWhen did the new requirements for “Sequence Listing XML” submissions take effect?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The new requirements for “Sequence Listing XML” submissions took effect…
Read MoreWhen did the requirement for including an XML declaration in Sequence Listing XML become effective?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The requirement for including an XML declaration in Sequence Listing…
Read MoreWhen did the new requirements for “specifically defined” nucleotides and amino acids come into effect?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2412.03(a), the new requirements for “specifically defined”…
Read MoreWhat is the significance of the effective date on an ex parte reexamination certificate?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The effective date on an ex parte reexamination certificate is…
Read MoreWhen did the new requirements for nucleotide and amino acid sequence disclosures in patent applications take effect?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The new requirements for nucleotide and amino acid sequence disclosures…
Read MoreWhat is the effective date for applying AIA 35 U.S.C. 102(b)(2)(C) exception?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The effective date for applying the AIA 35 U.S.C. 102(b)(2)(C)…
Read MoreWhen did the requirement for a DOCTYPE declaration in Sequence Listing XML become effective?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The requirement for a DOCTYPE declaration in Sequence Listing XML…
Read MoreHow does the rectification of an obvious mistake affect the effective date of the PCT application?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The effect of rectifying an obvious mistake on the effective…
Read MoreWhen did the Japan Patent Office become available as an International Searching Authority for U.S. applicants?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The Japan Patent Office (JPO) became available as an International Searching Authority (ISA) for…
Read More